CClinicalTrials.gg
CompletedNCT01829789POPUpdated Sep 30, 2016

Individual vs. Group Community Reinforcement Training to Help Parents of Substance-using Treatment-refusing Youth

An interventional study of Group Community Reinforcement Training for Parents and Individual Community Reinforcement Training for Parents in Substance Use Disorders and Treatment Refusal, sponsored by Oregon Research Institute. Completed at 1 site in United States. Per ClinicalTrials.gov, last updated 2016-09-30.

Sponsored by Oregon Research Institute · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Randomized
Sex
All
01

Study summary

The purpose of this study is to test the efficacy and cost-effectiveness of Community Reinforcement Training (CRT) provided in a group therapy format. The goals of CRT are to teach parents behavioral and communication skills to influence their youth's drug use and encourage them to enter treatment. Thirty parents will be randomly assigned to Group CRT and 30 will be randomly assigned to traditional, Individual CRT. Youth engaged in treatment will receive individual Cognitive Behavioral Therapy. Families are assessed for adolescent substance use and other areas of individual and family functioning. It is expected that Group CRT will be more effective for encouraging youth entry into treatment and improving parental functioning.

Read the detailed description

Very few youth with drug abuse or dependence in the United States receive treatment. This population of untreated youth represents a massive "treatment gap" in adolescent health care that renders impotent a potentially important avenue for preventing chronic drug abuse and related difficulties. The lack of motivation for treatment characterizing most adolescent drug abusers significantly decreases the likelihood these youth will enter treatment, barring mandates from the legal system or other social institutions. Efficacy studies have demonstrated that Community Reinforcement Training (CRT), an approach that involves teaching parents how to engage their youth into treatment, can work to recruit 60-80% of these treatment-elusive youth. CRT is traditionally provided in an individual therapy format to one or both parents. This study will improve upon our prior work by using a group format to provide a less costly procedure for engaging youth into treatment and to make it more portable to treatment agencies, schools, juvenile justice, and other community organizations seeking to offer support to parents or engage youth in treatment, thus significantly increasing the adoption and sustainability of the approach.

This study will examine the efficacy of the group format (G-CRT) for helping parents engage their unmotivated, resistant youth in treatment compared to the traditional individual format (I-CRT). Parents (n = 60) will be randomly assigned to G-CRT or to I-CRT. We will evaluate the differential efficacy of G-CRT, relative to I-CRT, on rates of adolescent engagement in treatment. We expect that G-CRT, compared to I-CRT, will also be associated with greater parent encouragement of adolescent sobriety, perceived social support, and family functioning. We also predict that changes on these process variables will predict increased success in engaging adolescents. We will also examine treatment outcomes for youth engaged in Cognitive Behavioral Therapy as a function of parental involvement in G-CRT or I-CRT. We predict enhanced support received by parents in G-CRT will result in greater reductions in drug use and lower levels of HIV-risk behaviors, outcomes hypothesized to be mediated by motivation to change and sessions attendance. Finally, we will conduct an informal cost-effectiveness analysis to derive preliminary estimates of the relative costs of each treatment modality per outcome unit and hypothesize that G-CRT will be more cost effective than I-CRT by virtue of having higher clinical effectiveness and lower costs. Successful outcomes here will provide the basis for a full clinical trial with larger samples.

02

Conditions studied

  • Substance Use Disorders
  • Treatment Refusal

Keywords

  • Adolescents
  • Teens
  • Parents
  • Parenting
  • Substance Abuse
  • Treatment Efficacy
03

In context

Substance-Related Disorders

2,124 studies on the registry are indexed under Substance-Related Disorders; 393 are open to participants now.

This study's enrollment of 60 is below the median of 108 across 1,727 interventional studies indexed under Substance-Related Disorders.

Browse Substance-Related Disorders studies →

Lead sponsor

Oregon Research Institute is the lead sponsor of 70 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Parents have an adolescent between 15-20 years
  • Parents have had contact with the adolescent on at least 40% of the past 12 weeks
  • Parents have some knowledge or evidence that the adolescent would meet DSM-IV diagnostic criteria for a substance use disorder
  • Adolescent has explicitly refused to attend any intake or therapy sessions
  • Adolescent is not under a current court mandate for treatment or has refused to comply with the mandate
  • English-speaking capability (parents and adolescents)

Exclusion criteria

Exclusion Criteria:

  • Evidence of adolescent psychotic or organic state of sufficient severity to interfere with understanding of study instruments and procedures
  • Adolescent had received drug treatment (except detoxification) in the past 12 weeks.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
60 participants (actual)

Study arms

  • Experimental
    G-CRT

    Group Community Reinforcement Training for parents

    Behavioral: Group Community Reinforcement Training for Parents

  • Active comparator
    I-CRT

    Individual Community Reinforcement Training for parents

    Behavioral: Individual Community Reinforcement Training for Parents

Interventions

  • BehavioralGroup Community Reinforcement Training for Parents

    Also known as: G-CRT

  • BehavioralIndividual Community Reinforcement Training for Parents

    Also known as: I-CRT

06

What researchers measure

Primary outcomes

  1. Adolescent treatment engagement

    An adolescent may enter the CBT treatment program ("treatment engagement") at any point during the 4-month time period after his or her parents begin I-CRT or G-CRT therapy.

    Time frame: 4 months

Secondary outcomes

  1. Timeline Followback (TLFB) interview

    The TLFB is an interview to assess the quantity, frequency, and pattern of illicit substance use. Parents provide collateral data on their adolescents' substance use in the 3 months prior to enrollment. Adolescents report on their own substance use for the 3 months prior to their parents' enrollment through 6 months after enrollment.

    Time frame: 9 months

Other outcomes

  1. Medical Outcome Studies Social Support Survey

    The MOS consists of four support subscales (Emotional/Informational, Tangible, Affectionate, and Positive Social) and an overall functional social support index. This measure will be completed by parents at baseline (about the 3 months prior to enrollment) and at 3- and 6-month follow-up points. It will be used to compare perceived social support for parents in the G-CRT versus I-CRT interventions.

    Time frame: 9 months

07

Study locations

1 site
  • Center for Family and Adolescent Research
    Portland, Oregon 97232, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01829789
Lead sponsor
Oregon Research Institute
Responsible party
Sponsor
First posted
Apr 11, 2013
Start date
Apr 2013
Primary completion
Nov 2015
Completion
Mar 2016
Last update
Sep 30, 2016

Study contacts

Erica M Finstad, Ph.D.
principal investigator · Oregon Research Institute

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion